STAT+: Pharmalittle: We’re reading about a lawsuit over lab tests for meds, a Bristol myeloma drug, and more
World1 source1 country🔦 Under-reported46m ago
Recent industry reporting highlights several major developments in the pharmaceutical sector, including a new multiple myeloma approval for Bristol Myers Squibb and a legal dispute concerning laboratory tests for medications. Additionally, major pharmacy benefit managers (PBMs) have agreed to display TrumpRx drug prices and integrate price comparisons into their systems.
In intellectual property and international markets, Novartis secured a significant victory by winning a key United Kingdom patent fight regarding its heart medication Entresto. These updates collectively point to ongoing shifts in drug pricing transparency, regulatory approvals, and corporate litigation within the healthcare industry.
In-depth summary · AI, neutral
How the coverage differs
Same story, different emphasis — here's what each outlet chose to lead with.
STAT News (US)Focuses on specific pharma developments including TrumpRx prices and Entresto
STAT News (US) (US)Emphasizes the end of the work week and upcoming weekend plans
Newz